Skip to content

Decreasing social jetlag with blue-light reducing glasses in the evening compared to blue-LED-light emitting glasses in the morning

Decreasing social jetlag with blue-light reducing glasses in the evening compared to blue-LED-light emitting glasses in the morning - Decreasing social jetlag by controlling blue light

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41846
Enrollment
30
Registered
2015-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep deprivation and social jetlag sleep deprivation and circadian misalignment

Interventions

Short wavelength (blue) light reducing orange glasses (blue light absorption >93%
appendix D1b
experimental condition 1) for seven days for at least three hours before sleep time (lights out
when waking up during the night, e.g. to use the toilet, participants will be asked to put on the glasses before switching on the room lights), and blue-LED-light emitting glasses (www.enwake.me
comparable to the Philips goLITEblu devices
appendix D1c
experimental condition 2) for two hours after wake up. The order of experimental glasses 1 and 2 will be randomized.

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy men and women between 18 and 45 years of age Social jetlag = difference between mid-sleep on workdays and days off of minimum 2 hours Written informed consent

Exclusion criteria

Exclusion criteria: • Sleep disorders, e.g. sleep apnoea, narcolepsy, restless legs, primary insomnia (will be asked in the General Questionnaire, appendix F1a) • Mood disorder; because of the possibility of depressive mood as co-morbidity in late chronotypes we will exclude depressed participants • Two or more time zones crossed 1 month before study participation • Shift-work during 5 years prior to participation • Recent eye surgery (last year), glaucoma or other eye disease • History of chronic diseases, and/or use of chronic medication for 3 months or longer before study participation • Alcohol/drug problems (based on answers to General Questionnaire, appendix F1a) • The use of photosensitizing medication • Wearing spectacles already (contact lenses allowed) • Sleeping with open curtains in the bedroom • Pregnancy; because sleep (one of our main outcome measurement) can be disturbed during pregnancy

Design outcomes

Primary

MeasureTime frame
Sleep timing from sleep diaries (subjective) and rest/activity profiles from actimetry (objective) and endogenous circadian phase of melatonin from saliva samples; the start of the rhythm will be measured: dim light melatonin onset (DLMO). A shift in DLMO is interpreted as a shift in the endogenous circadian pacemaker.

Secondary

MeasureTime frame
Sleep quality from subjective sleep diaries, light exposure assessed from sleep diaries (subjective) and from actimetry (objective).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)